ReviewInternational journal of physiology, pathophysiology and pharmacology2025
The dual role of SGLT2 inhibitors: glycemic control and cardioprotection in anthracycline-treated cancer patients.
Azad MojahediPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.